Insider Deck research · News

REGN stock news · Regeneron Pharmaceuticals, Inc.

Latest Regeneron Pharmaceuticals, Inc. (REGN) stock news, headlines, and research context on Insider Deck. Market cap $79.1B.

News desk

Regeneron Pharmaceuticals, Inc. wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

8 on the wireUpdated within the hour

Zacks·Wed, Aug 5, 4:20 PM

Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock

Regeneron (REGN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Insider Deck desk note

Last$768.58
Day+1.04%
SymbolREGN

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on Zacks

Frequently asked questions

What is the latest news on REGN?

The REGN news desk aggregates recent headlines with research context for Regeneron Pharmaceuticals, Inc..

Where can I research REGN on Insider Deck?

Regeneron Pharmaceuticals, Inc. (REGN) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.